The Case Comprehensive Cancer Center’s Specialized Program of Research Excellence in Gastrointestinal Malignancies (GI SPORE) is pleased to announce a new funding opportunity. All faculty members are invited to submit project proposals to compete for R01 level funding for up to three (3) years by selection for incorporation as a full project in the current Case GI SPORE program, with potential for renewal for an additional five (5) years of funding contingent on the future competitive renewal of the GI SPORE program.
All proposals must be directed toward translational research of a GI malignancy with at least one specific aim that involves direct study of patients or of consented human tissues as defined in the SPORE RFA.
Proposals must include two project leaders; one basic science leader and one clinical leader. Maximum funding for this RFA is $186,000 per year of direct costs for three years, for a total of $558,000 in direct costs.